en
Scientific article
Open access
English

Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries

Published inThe Lancet Regional Health - Western Pacific, vol. 11, 100147
Publication date2021
Abstract

Background: We aimed to estimate the disease burden of Tuberculosis (TB) and return on investment of TB care in selected high-burden countries of the Western Pacific Region (WPR) until 2030. Methods: We projected the TB epidemic in Viet Nam and Lao People's Democratic Republic (PDR) 2020–2030 using a mathematical model under various scenarios: counterfactual (no TB care); baseline (TB care continues at current levels); and 12 different diagnosis and treatment interventions. We retrieved previous modeling results for China and the Philippines. We pooled the new and existing information on incidence and deaths in the four countries, covering >80% of the TB burden in WPR. We estimated the return on investment of TB care and interventions in Viet Nam and Lao PDR using a Solow model. Findings: In the baseline scenario, TB incidence in the four countries decreased from 97•0/100,000/year (2019) to 90•1/100,000/year (2030), and TB deaths from 83,300/year (2019) to 71,100/year (2030). Active case finding (ACF) strategies (screening people not seeking care for respiratory symptoms) were the most effective single interventions. Return on investment (2020–2030) for TB care in Viet Nam and Lao PDR ranged US$4-US$49/dollar spent; additional interventions brought up to US$2•7/dollar spent. Interpretation: In the modeled countries, TB incidence will only modestly decrease without additional interventions. Interventions that include ACF can reduce TB burden but achieving the End TB incidence and mortality targets will be difficult without new transformational tools (e.g. vaccine, new diagnostic tools, shorter treatment). However, TB care, even at its current level, can bring a multiple-fold return on investment.

Keywords
  • Tuberculosis
  • Mathematical model
  • Health economics
  • Return on investment
  • Western Pacific Region
Funding
  • Swiss National Science Foundation - 163878
  • Autre - World Health Organization Western Pacific Regional Office
Citation (ISO format)
ESTILL, Janne Anton Markus et al. Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries. In: The Lancet Regional Health - Western Pacific, 2021, vol. 11, p. 100147. doi: 10.1016/j.lanwpc.2021.100147
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2666-6065
141views
55downloads

Technical informations

Creation05/19/2021 4:24:00 PM
First validation05/19/2021 4:24:00 PM
Update time03/16/2023 1:27:00 AM
Status update03/16/2023 1:26:58 AM
Last indexation05/06/2024 8:16:21 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack